⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14328614 | 0.72 | — | — | |
| SCHEMBL8622641 | 0.72 | — | — | |
| SCHEMBL242298 | 0.72 | — | — | |
| SCHEMBL14328633 | 0.68 | — | — | |
| SCHEMBL16302109 | 0.68 | — | — | |
| SCHEMBL6250433 | 0.61 | — | — | |
| SCHEMBL8090012 | 0.50 | — | — | |
| SCHEMBL60553 | 0.50 | — | — | |
| SCHEMBL1074378 | 0.50 | — | — | |
| Methyl Alcohol SCHEMBL37 | 0.47 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1569697-B1 | WOUND DRESSINGS COMPRISING VANADATE COMPLEXED WITH ORGANIC LIGANDS | JOHNSON & JOHNSON MEDICAL LTD (GB) | 2008-11-12 | — | — | EP | claimed |
| WO-2007033175-A1 | INDOLOBENZAZEPINE HCV NS5B INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-03-22 | — | — | WO | claimed |
| WO-1996000219-A1 | PYRIMIDINYL- AND TRIAZINYL-OXY AND THIO-3-HALOALKYL-PROPIONIC ACID DERIVATIVES AS HERBICIDES | CIBA-GEIGY AG (CH) | 1996-01-04 | — | — | WO | claimed |
| US-12018002-B2 | Certain chemical entities, compositions, and methods | NEUPHARMA, INC (US) | 2024-06-25 | — | — | US | disclosed |
| US-20240197752-A1 | SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY | NEUPHARMA INC | 2024-06-20 | — | — | US | disclosed |
| WO-2024086826-A2 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-04-25 | — | — | WO | disclosed |
| US-20240115585-A1 | METHODS OF TREATING CANCER | NEUPHARMA, INC. | 2024-04-11 | — | — | US | disclosed |
| CN-117642419-A | Compounds and compositions for targeted treatment of kidney disease | 上海盟科药业股份有限公司 | 2024-03-01 | — | — | CN | disclosed |
| WO-2024044651-A2 | DEGRADABLE POLYURETHANES CONTAINING SILYL ETHER LINKERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-02-29 | — | — | WO | disclosed |
| EP-4308566-A1 | PURINE DERIVATIVES AS ANTICANCER AGENTS | Tango Therapeutics, Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| US-11865120-B2 | Substituted quinazolines for inhibiting kinase activity | NEUPHARMA, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| WO-2001017982-A1 | BENZOPHENONES AS INHIBITORS OF REVERSE TRANSCRIPTASE | GLAXO GROUP LIMITED (GB) | 2001-03-15 | — | — | WO | disclosed |
| EP-1075467-A1 | PYRAZOLE DERIVATIVES AS P-38 MAP KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-02-14 | — | — | EP | disclosed |
| WO-2000031033-A1 | PIPERIDINE CCR-3 RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-02 | — | — | WO | disclosed |
| WO-2000029377-A1 | 4-AROYL-PIPERIDIN-CCR-3 RECEPTOR ANTAGONISTS III | F. HOFFMANN-LA ROCHE AG (CH) | 2000-05-25 | — | — | WO | disclosed |
| WO-1999057101-A1 | PYRAZOLE DERIVATIVES AS P-38 MAP KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 1999-11-11 | — | — | WO | disclosed |
| WO-1996000219-A1 | PYRIMIDINYL- AND TRIAZINYL-OXY AND THIO-3-HALOALKYL-PROPIONIC ACID DERIVATIVES AS HERBICIDES | CIBA-GEIGY AG (CH) | 1996-01-04 | — | — | WO | disclosed |
| EP-0172321-B1 | SQUARYLIUM CHARGE GENERATING DYE AND ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR | International Business Machines Corporation (US) | 1987-11-19 | — | — | EP | disclosed |
| US-4677045-A | NON-MUTAGENIC | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1987-06-30 | — | — | US | disclosed |
| EP-0172321-A2 | Squarylium charge generating dye and electrophotographic photoconductor | International Business Machines Corporation (US) | 1986-02-26 | — | — | EP | disclosed |